Company: RGNT
Filing Date: 2025-05-05
Form Type: F-1/A
Source: 0001213900-25-039589
Chunk: 45

Company: REGENTIS BIOMATERIALS LTD.
Filing Date: 2025-05-05
Form: F-1/A
Chunk 45
---
 prospects.

<div align='center'>28</div>

Risks Related to Our Intellectual Property

If we are unable to obtain significant patent protection for our products, or if our patents and other intellectual property rights do not adequately protect our products, we may be unable to gain significant market share and be unable to operate our business profitably.

We will rely on patents, trade
secrets, copyrights, know-how, trademarks, license agreements and contractual provisions to establish our intellectual property rights
and protect our products. These legal means, however, afford only limited protection and may not completely protect our rights.

As of May 5, 2025,
our exclusively owned patent portfolio includes thirty-four (34) issued patents, of which eight (8) are U.S. patents and twenty-six (26)
are foreign patents, with eighteen (18) of the twenty-six (26) foreign patents being nationally validated in certain European extension/validation
states). We cannot assure you that our intellectual property position will not be challenged or that all patents for which we have applied
will be granted. The validity and breadth of claims in patents involves complex legal and factual questions and, therefore, may be highly
uncertain. Uncertainties and risks that we face include the following:

| ● | our pending or future patent applications may not result in the issuance of patents;                                                                                                                                                          |
| ● | the scope of any existing or future patent protection may not exclude competitors or provide competitive advantages to us;                                                                                                                    |
| ● | our patents may not be held valid or enforceable if subsequently challenged;                                                                                                                                                                  |
| ● | other parties may claim that our products and designs infringe the proprietary rights of others—even if we are successful in defending our patents and proprietary rights, the cost of such litigation may adversely affect our business; and |
| ● | other parties may develop similar products, duplicate our products, or design around our patents.                                                                                                                                             |

The patent prosecution process
is expensive and time-consuming, and we may not be able to file, prosecute, maintain, enforce or license all necessary or desirable patent
applications at a reasonable cost or in a timely manner, or in all jurisdictions. We may choose not to seek patent protection for certain
innovations and may choose not to pursue patent protection in certain jurisdictions, and under the laws of certain jurisdictions, patents
or other intellectual property rights may be unavailable or limited in scope. It is also possible that we will fail to identify patentable
aspects of our developments before it is too late to obtain